Disease-modifying activity of ruxolitinib in a patient with JAK2-negative CMML-2. Issue 5 (4th May 2017) - Francke, Silvan; Mies, Anna; Meggendorfer, Manja; Oelschlaegel, Uta; Balaian, Ekaterina; Gloaguen, Silke; Haferlach, Torsten; Ehninger, Gerhard; Bornhäuser, Martin; Platzbecker, Uwe